title: Abatacept use after failure of multiple biologic agents in patients with severe rheumatoid arthritis.
authors.affiliation: Division of Rheumatology, Mount Sinai Hospital, Toronto, Ontario, Canada. glen.hazlewood@utoronto.ca
authors.forename: Glen S
authors.initials: GS
authors.lastname: Hazlewood
authors.forename: Cheryl
authors.initials: C
authors.lastname: Barnabe
authors.forename: Susan G
authors.initials: SG
authors.lastname: Barr
authors.forename: Liam
authors.initials: L
authors.lastname: Martin
mesh_terms: D000069594:Abatacept; D000328:Adult; D000368:Aged; D018501:Antirheumatic Agents / Q000627:therapeutic use*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D004185:Disability Evaluation; D005260:Female; D006801:Humans; D018796:Immunoconjugates / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D012074:Remission Induction; D012720:Severity of Illness Index; D017211:Treatment Failure
chemical_list: D018501:Antirheumatic Agents; D018796:Immunoconjugates; D000069594:Abatacept